drugset / Trial / NCT07796074
Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 2
Phase 2
Recruiting
36 enrolled
Yale University
National Headache Foundation · collabVA Connecticut Healthcare System · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Anesthetic greater occipital nerve (GON) blockade is a simple, inexpensive, and safe procedure that has demonstrable headache pain suppressing effects. In this study, Veterans with post-traumatic headache will be randomized to receive 0.0%, 0.05%, or 0.5% bupivacaine in bilateral GON blocks and the lasting (i.e., transitional) effects on headache frequency measured in a headache diary.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2027-09-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.05 % | Subcutaneous |
| Subject | Bupivacaine | Other / unclassified | 0.5 % | Subcutaneous |
Indications
No indication recorded.